Folgen
-
In this episode, University of Queensland virologist, Dr Kirsty Short, helps to unpack where vaccines began, and the exciting inroads being made in modern vaccine science. Since completing her PhD in 2013, Dr Short has dedicated her research to vaccine-preventable diseases and is a passionate believer in the role of science in protecting against infectious diseases.
This podcast is not intended to replace the advice of a doctor, and listeners should direct any queries they have about immunisation or vaccines to their doctor.
The views and opinions expressed in the podcast series should not be attributed to any organisation with which the speakers are employed or affiliated and are not necessarily the views of Sanofi Pasteur Australia.
Sanofi‐Aventis Australia Pty Ltd. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2102339. Date of preparation: November 2021.
-
In this episode we talk to Catherine Hughes, founder of the Immunisation Foundation Australia, about how family tragedy led to the formation of a community-based immunisation advocacy organisation dedicated to helping protect Australians from vaccine-preventable diseases.
This podcast is not intended to replace the advice of a doctor, and listeners should direct any queries they have about immunisation or vaccines to their doctor.
The views and opinions expressed in the podcast series should not be attributed to any organisation with which the speakers are employed or affiliated and are not necessarily the views of Sanofi Pasteur Australia.
Sanofi‐Aventis Australia Pty Ltd. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2102341 Date of preparation: November 2021.
-
Fehlende Folgen?
-
Leading researcher and virologist at the University of Queensland, Dr Kirsty Short tackles some of the myths and misunderstandings that continue to surround vaccines – from how they work, how they’re researched, and how our body responds to vaccination.
This podcast is not intended to replace the advice of a doctor, and listeners should direct any queries they have about immunisation or vaccines to their doctor.
The views and opinions expressed in the podcast series should not be attributed to any organisation with which the speakers are employed or affiliated and are not necessarily the views of Sanofi Pasteur Australia.
Sanofi‐Aventis Australia Pty Ltd. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2102340. Date of preparation: November 2021.
-
We pick the brain one of the world’s preeminent experts in vaccine development, Professor David Greenberg, Global Medical Head of Sanofi Pasteur based in Lyon, France, to find out what goes into researching and responding to infectious diseases and what’s on the horizon for vaccine science.
This podcast is not intended to replace the advice of a doctor, and listeners should direct any queries they have about immunisation or vaccines to their doctor.
The views and opinions expressed in the podcast series should not be attributed to any organisation with which the speakers are employed or affiliated and are not necessarily the views of Sanofi Pasteur Australia.
Sanofi‐Aventis Australia Pty Ltd. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2102342. Date of preparation: November 2021.
-
In this episode we talk to Associate Professor Paul Griffin, Director of Infectious Diseases at Mater Health in Queensland, about COVID-19 and influenza – spelling out the differences between these two viruses, and whether our understanding of influenza may help guide how we curb the impact of COVID-19 in the future.
This podcast is not intended to replace the advice of a doctor, and listeners should direct any queries they have about immunisation or vaccines to their doctor.
The views and opinions expressed in the podcast series should not be attributed to any organisation with which the speakers are employed or affiliated and are not necessarily the views of Sanofi Pasteur Australia.
Sanofi‐Aventis Australia Pty Ltd. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2102343. Date of preparation: November 2021.
